T. Rowe Price Investment Management, Inc.

Position in PRGO — PERRIGO Co plc

CIK 1897612 BALTIMORE, MD

Back to PRGO Full portfolio

Position in PRGO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,429,215

-$1,865,450 QoQ

Shares Held

1,622,832

+17.1% QoQ

Ownership

1.17%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $877,868,421 across 3 Drug Manufacturers - Specialty & Generic names. PRGO ranks #3 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	34,635,086	$828,817,607
2	ALKS	Alkermes plc.	894,276	$31,621,599
3	PRGO	PERRIGO Co plc This page	1,622,832	$17,429,215

All Filings in PRGO

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,429,215	1,622,832	+17.1%	Shares	Sole	2026-05-15
2025-12-31	$19,294,665	1,386,111	+35.5%	Shares	Sole	2026-02-19
2025-09-30	$22,773,524	1,022,610	-44.3%	Shares	Sole	2025-11-14
2025-06-30	$49,033,230	1,835,076	+4.0%	Shares	Sole	2025-08-14
2022-09-30	$62,931,769	1,764,772	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.